ArticleAmerican journal of cancer research2021

TSL-1502, a glucuronide prodrug of a poly (ADP-ribose) polymerase (PARP) inhibitor, exhibits potent anti-tumor activity in preclinical models.

Lei Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.